Skip to content
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Menu
  • Happy Health
  • Happy Mindset
  • Animal Wonders
  • About Us
    • Team
  • Subscribe
Happy News

A Pill That Costs Pennies And Has Been Around For 125 Years May Also Fight Cancer

A pill that has been sitting in medicine cabinets for more than a century is showing signs of being far more powerful than anyone originally imagined, as a growing body of clinical evidence points to aspirin as a meaningful weapon against cancer. Researchers at the Karolinska Institute in Sweden tracked nearly 3,000 bowel cancer patients and found that those taking just 160mg of aspirin daily had less than half the risk of cancer recurrence compared to those on a placebo, results so striking that Sweden began screening bowel cancer patients for specific tumor mutations from January 2026 and offering low-dose aspirin to those who test positive. Scientists have identified two distinct biological mechanisms behind this: aspirin reduces inflammation that tumors exploit to grow and spread, and it blocks a clotting factor that suppresses the immune system’s ability to detect and destroy cancer cells, making tumors more visible to the body’s own defenses. Guidelines in the UK were already updated in 2020 to recommend aspirin for people with Lynch Syndrome from around age 20.

Now a much larger trial is underway to find out how far these effects extend. Led by Professor Ruth Langley at University College London, the study involves 11,000 participants across the UK, Ireland, and India who have previously had colorectal, breast, gastroesophageal, or prostate cancer, testing whether a daily low-dose aspirin can prevent recurrence across all four types, with results expected next year. Researchers are careful to note that aspirin carries real risks including internal bleeding and stomach ulcers, and stress that no one should start taking it for cancer prevention without speaking to a doctor first. But for a drug that costs pennies a day and has been in use for more than 125 years, the emerging evidence that it may also be one of the most broadly effective cancer-fighting tools ever discovered is a development the medical world is watching with very considerable excitement.

Source: https://www.bbc.co.uk/future/article/20260420-cancer-how-aspirin-may-be-a-powerful-new-weapon-against-tumours

PrevPreviousDoctors Just Gave 133 People Their Sight Back For Free

Recent Articles

Happy News

A Runner Broke The Two-Hour Barrier For The First Time Ever

April 27, 2026

Something happened today at the TCS London Marathon that the running world has been chasing for decades. Kenyan runner Sabastian Sawe crossed the finish line in 1:59:30 — making him the first person in history to run a marathon in under two hours under official, record-eligible conditions. That is not

Read More
Happy News

6500 Volunteers Just Built 10000 Beds In A Day For Kids Who Have Never Had One

April 27, 2026

More than 140,000 children across the United States do not have a bed to sleep in, and this week a group of 6,500 volunteers decided to make a serious dent in that number, gathering at the Charlotte Convention Center in North Carolina and building over 10,000 beds in just 24

Read More
Happy News

The FDA Just Approved The First Gene Therapy For Inherited Deafness And The Company Is Making It Free

April 27, 2026

The Food and Drug Administration has approved the first ever gene therapy for inherited hearing loss, a one-time treatment developed by Regeneron Pharmaceuticals that has proven life-changing for children born deaf due to a mutation in a gene called OTOF, which the ear needs to transmit sound signals to the

Read More
« Previous Next »
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
  • Privacy Notice
  • Accessibility Notice
  • Do Not Sell or Share My Personal Information
  • Unsubscribe
  • Terms and Conditions
  • Privacy Policy
Copyright © 2026 HappyNews.